Down-regulation of ColIA, ColIVA, and Fn1 and up-regulation of LVD, MMP-1, MMP-2, and uPA might be important features of OSCC progression, which may exert their functions and favorably predict lymphatic dissemination for OSCC patients at relatively early stage. Among these biomarkers, increased LVD is an independent risk factor of lymphatic metastasis, which could better predict whether metastasis will occur or not.
The structural advantages of metal-organic frameworks (MOFs) can facilitate wide applications in the field of catalysis, including oxidation, hydrogenation, acetalization, transesterification, catalytic cracking, and so on. The efficiency of catalysis is closely related to the synergy between active center, auxiliary center, and microenvironment. Researchers can customize MOFs according to the needs of catalytic reactions, and many strategies were established for boosting catalytic performance. In this review, we aim to summarize and illustrate recent progress in the nanospace engineering of MOFs. Generally, MOFs were engineered mainly from the following aspects: 1) Regulation of pore size, including micropores, mesopores, and macropores. 2) Engineering of encapsulated active species, such as metal nanoparticles, quantum dots, polyoxometalates, enzymes, etc. 3) Engineering of MOFs morphology from zero dimension to three-dimension. 4) Controllable integration of MOFs with multi-strategies. 5) Construction of multivariate MOFs via introducing multiple or mixed organic functional groups into the existing framework. Besides, for further low cost and practical applications, challenges for MOFs as green and sustainable catalysts are also discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.